Company Filing History:
Years Active: 2010-2019
Title: Nathan Gordon: Innovator in Fluid Separation Technologies
Introduction
Nathan Gordon is a notable inventor based in Plymouth, Indiana, who has made significant contributions to the field of fluid separation technologies. With a total of five patents to his name, Gordon has developed innovative methods and apparatuses that enhance the efficiency of separating and concentrating fluids containing multiple components.
Latest Patents
One of Nathan Gordon's latest patents is an apparatus and method for separating and concentrating fluids containing multiple components. This apparatus allows for the separation and collection of fractions from a sample, utilizing a centrifuge to create at least three distinct fractions. It introduces a new method for extracting the buffy coat phase from whole blood samples and mesenchymal stem cells from bone reaming material. Additionally, the design incorporates a buoy system that includes a first buoy portion and a second buoy member, which work together to facilitate the formation of multiple fractions during a single centrifugation process. This innovation significantly improves the speed and efficiency of fluid separation.
Career Highlights
Throughout his career, Nathan Gordon has worked with prominent companies in the medical and manufacturing sectors, including Biomet Biologics, LLC and Biomet Manufacturing Corporation. His experience in these organizations has allowed him to refine his skills and contribute to advancements in medical technologies.
Collaborations
Nathan has collaborated with several professionals in his field, including Joel C. Higgins and Matthew Swift. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Nathan Gordon's work in fluid separation technologies exemplifies the impact of innovative thinking in the medical field. His patents and career achievements highlight his dedication to improving processes that benefit various applications.